Day: June 7, 2021
McNatt will lead the company’s center of excellence for investment solutions and experience
CONCORD, Calif., June 07, 2021 (GLOBE NEWSWIRE) — AssetMark (NYSE: AMK) announced it has named David McNatt, CFA, as Executive Vice President, Head of Investment Solutions. He was most recently Senior Vice President, Product Strategy and Management for AssetMark. With this promotion, McNatt joins the AssetMark Executive Team under CEO Natalie Wolfsen.
McNatt has led Product Strategy and Management for the last six years, responsible for managing solutions across the development lifecycle, driving adoption and optimizing revenue. Previously, he held senior leadership roles at Russell Investments, Charles Schwab and Franklin Templeton. In his career, McNatt has developed and launched more than 45 products and services representing $160B in...
FDCTech Completes Transformative Acquisition of Genesis Financial, Inc.
Written by Customer Service on . Posted in Public Companies.
The acquisition of Genesis Financial is a step–change in creating a diversified global financial services company with annualized revenue of $15 million and well-positioned for long-term growth through FDCTech‘s proprietary Condor trading infrastructure, complementary multi-jurisdiction regulatory licenses, proven executive team, and pipeline of potential acquisitions.
Irvine, CA, June 07, 2021 (GLOBE NEWSWIRE) — FDCTech, Inc. (“FDC” or the “Company,” OTCQB: FDCT), a fintech company with a full suite of digital financial services solutions, today announced that it had entered into a purchase agreement (“Agreement”) under which the Company will acquire up to 100% equity interest in Genesis Financial, Inc. (“GFNL”) in a stock-for-stock transaction.
Under the terms of the...
Adial Pharmaceuticals Comments on Article in ‘The Atlantic,’ Highlighting the Second Pandemic of Addiction
Written by Customer Service on . Posted in Public Companies.
CHARLOTTESVILLE, Va., June 07, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, commends Kate Julian and The Atlantic for highlighting the major crisis facing our society in her article America Has a Drinking Problem. The article highlights the complexity of the factors driving alcohol use and its pervasiveness in human society and, particularly, in the United States.
William Stilley, Chief Executive Officer of Adial, commented, “We appreciate the spotlight that Ms. Julian and The Atlantic have put on the increase in Alcohol Use Disorder (AUD), which has been exacerbated by the COVID-19 induced lockdowns—the ‘Second Pandemic of Addiction,’...
iBrands Corporation Appoints New CEO And Changes Business Focus
Written by Customer Service on . Posted in Public Companies.
LAS VEGAS, June 07, 2021 (GLOBE NEWSWIRE) — iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holdings company, is pleased to announce the appointment of Billionaire Frank Ekejija as its new Chairman, President and CEO and changed the company’s business focus, respectively.
“iBrands Corporation has an enormous intrinsic value because we have loaded the basis for the benefit of the shareholders and stakeholders. Moving forward the company will be engaged in providing Merchant / Private Banking, Venture Capital, Asset Management and Wealth Creation Services to public and private companies. iBrands Corporation is well capitalized to support our admitted partners and clients operations around the world. We are strategically situated and positioned to serve the capital markets,” said Frank Ekejija, new Chairman, President...
Chicken Soup for the Soul Entertainment’s Screen Media Acquires North American Rights to Zac Efron Survival Thriller ‘GOLD’
Written by Customer Service on . Posted in Public Companies.
COS COB, Conn., June 07, 2021 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced the Screen Media acquisition of all North American rights to writer / director Anthony Hayes’ upcoming thriller GOLD, in which he co-stars with Zac Efron (The Greatest Showman, Extremely Wicked, Shockingly Evil and Vile), and Susie Porter (The Monkey’s Mask, Cargo). Hayes is known for memorable roles in Animal Kingdom, The Square and The Slap. Following a competitive bidding war among many contenders at last year’s AFM, Screen Media came out on top, purchasing the film, which was filmed in South Australia late last year, and is currently in post-production.
GOLD is about greed and the lengths people will go to...
Slinger Bag to Present at LD Micro Invitational XI Event
Written by Customer Service on . Posted in Public Companies.
BALTIMORE, June 07, 2021 (GLOBE NEWSWIRE) — Slinger Bag Inc. (OTCQB: SLBG), a sports brand launched in 2020 and focused on innovating game improvement equipment for all ball sports with an initial focus on the global tennis market, today announced that Mike Ballardie, Slinger Chief Executive Officer, will be presenting at the LD Micro Invitational XI virtual investor conference on day one, June 8, 2021 at 11:30 AM EDT.
LD Micro is the host of the most influential conferences in the small-cap world. The Invitational, in particular, is unique. Day one celebrates the Hall of Fame, highlighting some of the top performers since the conference’s beginnings in 2008. Day two and three focus on newcomers and companies on the “cusp” of doing big things. Slinger Bag was invited to the event as one of the companies to present during the Hall...
22nd Century Announces $40 Million Common Stock Registered Direct Offering
Written by Customer Service on . Posted in Public Companies.
Financing Provides Support to the Company’s Strategic Objectives Across All Its Plant Franchises.
BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it has entered into a definitive agreement with one institutional investor for the sale of 10 million shares of its common stock at a purchase price of $4.00 per share in a registered direct offering for gross proceeds for $40 million. The offering is expected to close on or about June 9, 2021, subject to the satisfaction of customary closing conditions.
“As a result of this important straight common equity financing with one of our long-term institutional investors, 22nd Century will be...
Vintage Wine Estates and Bespoke Capital Acquisition Corp. Announce Closing of Business Combination
Written by Customer Service on . Posted in Mergers And Acquisitions.
Common Stock to Commence Trading on the Nasdaq Global Market Under New Symbol “VWE” on June 8
SANTA ROSA, Calif. and INCLINE VILLAGE, Nev., June 07, 2021 (GLOBE NEWSWIRE) — Vintage Wine Estates (“VWE” or the “Company”), one of the fastest growing U.S. wine producers with an industry leading direct-to-consumer platform, today announced that it has completed its previously announced business combination with Bespoke Capital Acquisition Corp. (NASDAQ: BSPE) (TSX: BC.U) (TSX: BC.WT.U) (“Bespoke” or “BCAC”), a publicly-traded special purpose acquisition company.
The transaction, which was approved by BCAC shareholders at its meeting held on May 28, 2021, and also obtained approval from VWE shareholders, resulted in the combined company being renamed “Vintage Wine Estates, Inc.” At the opening of trading on Tuesday, June 8, 2021, its...
Exclusion of AS VALMIERAS STIKLA ŠĶIEDRA shares from the regulated market
Written by Customer Service on . Posted in Public Companies.
AS VALMIERAS STIKLA ŠĶIEDRA informs that on June 7, 2021 it submitted an application to AS “Nasdaq Riga” for exclusion of bearer shares from the Baltic Secondary List of AS “Nasdaq Riga”.The application has been submitted on the basis of 29 March 2021 the extraordinary shareholders’ meeting decision.
Additional information:AS VALMIERAS STIKLA ŠĶIEDRATel.: +371 6420 2216E-mail: latvia@valmiera-glass.comwww.valmiera-glass.com
Adhera Therapeutics Signs Letter of Intent with Melior Pharmaceuticals II to Acquire a New Class of Drug for Parkinson’s Disease
Written by Customer Service on . Posted in Public Companies.
Adhera to acquire and develop MLR-1019 (armesocarb), the API in mesocarb – a drug previously sold in Europe for 37 years – for Parkinson’s Disease
MLR-1019, a Phase 2-ready product, could have substantial benefits over today’s Parkinson’s drugs, including being the first to address both movement and non-movement symptomsBaton Rouge, LA, June 07, 2021 (GLOBE NEWSWIRE) — Adhera Therapeutics, Inc. (OTCPK: ATRX) (“Adhera” or the “Company”), a clinical stage biopharmaceutical company, is pleased to announce that the Company has signed a Letter of Intent (LOI) with Melior Pharmaceuticals II, LLC (“Melior Pharma 2”), pursuant to which Adhera will acquire MLR-1019 (armesocarb) from Melior Pharma 2. MLR-1019 is being developed as a new class of therapeutic for Parkinson’s disease (PD) and is, to the best of the...